News Announcement

Marksans Pharma: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the audio recording of the Q2FY23 & H1FY23 Results Conference Call is hosted on the website of the Company under the following link: http://marksanspharma.com/investors-meet.htmI

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.